PTC Therapeutics Inc (PTCT) Insider Trading
- $31,673,582.00
- $163,747,147.72
- May 16, 2025
- Stuart Walter Peltz
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 16, 2025 | VP | 883 | $46.02 | Sell | $40,635.66 | |
May 15, 2025 | VP | 1,929 | $46.18 | Sell | $89,081.22 | |
April 22, 2025 | CEO | 2,804 | $48.74 | Sell | $136,666.96 | |
April 2, 2025 | EVP | 897 | $46.95 | Sell | $42,114.15 | |
March 13, 2025 | Director | 5,000 | $54.00 | Sell | $270,000.00 | |
March 12, 2025 | VP | 15,521 | $53.30 | Sell | $827,269.30 | |
March 4, 2025 | Director | 1,230 | $51.52 | Sell | $63,369.60 | |
Feb. 19, 2025 | VP | 1,333 | $50.10 | Sell | $66,783.30 | |
Feb. 19, 2025 | Insider | 1,300 | $50.10 | Sell | $65,130.00 | |
Feb. 19, 2025 | EVP | 795 | $50.10 | Sell | $39,829.50 | |
Feb. 19, 2025 | CAO | 879 | $50.10 | Sell | $44,037.90 | |
Feb. 19, 2025 | CFO | 1,168 | $50.10 | Sell | $58,516.80 | |
Feb. 19, 2025 | CEO | 1,378 | $50.10 | Sell | $69,037.80 | |
Jan. 7, 2025 | CEO | 1,599 | $45.34 | Sell | $72,498.66 | |
Jan. 7, 2025 | EVP | 810 | $45.34 | Sell | $36,725.40 | |
Jan. 7, 2025 | Insider | 1,265 | $45.34 | Sell | $57,355.10 | |
Jan. 7, 2025 | CAO | 1,291 | $45.34 | Sell | $58,533.94 | |
Jan. 7, 2025 | VP | 1,543 | $45.34 | Sell | $69,959.62 | |
Dec. 31, 2024 | CEO | 8,279 | $45.16 | Sell | $373,879.64 | |
Dec. 2, 2024 | CAO | 17,800 | $51.77 | Sell | $921,506.00 | |
Dec. 2, 2024 | Insider | 69,550 | $52.06 | Sell | $3,620,773.00 | |
Dec. 2, 2024 | VP | 85,600 | $52.26 | Sell | $4,473,456.00 | |
Dec. 2, 2024 | Director | 24,000 | $51.50 | Sell | $1,236,000.00 | |
July 16, 2024 | CFO | 2,269 | $34.02 | Sell | $77,191.38 | |
May 22, 2024 | Director | 20,000 | $38.24 | Sell | $764,800.00 | |
May 7, 2024 | EVP | 175 | $32.82 | Sell | $5,743.50 | |
April 19, 2024 | CEO | 3,361 | $24.89 | Sell | $83,655.29 | |
April 17, 2024 | CEO | 787 | $25.14 | Sell | $19,785.18 | |
April 2, 2024 | EVP | 526 | $28.37 | Sell | $14,922.62 | |
Jan. 30, 2024 | VP | 794 | $27.25 | Sell | $21,636.50 | |
Jan. 30, 2024 | Insider | 618 | $27.25 | Sell | $16,840.50 | |
Jan. 30, 2024 | CAO | 318 | $27.25 | Sell | $8,665.50 | |
Jan. 22, 2024 | Director | 10,000 | $27.38 | Sell | $273,800.00 | |
Jan. 8, 2024 | CEO | 2,237 | $28.64 | Sell | $64,067.68 | |
Jan. 8, 2024 | VP | 1,457 | $28.64 | Sell | $41,728.48 | |
Jan. 8, 2024 | Insider | 1,569 | $28.64 | Sell | $44,936.16 | |
Jan. 8, 2024 | Director | 1,500 | $27.81 | Sell | $41,715.00 | |
Jan. 8, 2024 | CAO | 1,188 | $28.64 | Sell | $34,024.32 | |
Jan. 5, 2024 | CEO | 10,107 | $27.15 | Sell | $274,405.05 | |
Dec. 12, 2023 | CFO | 7,700 | $25.81 | Buy | $198,737.00 | |
Sept. 6, 2023 | Director | 11,666 | $39.86 | Sell | $465,006.76 | |
May 11, 2023 | Director | 23,000 | $55.08 | Sell | $1,266,840.00 | |
April 21, 2023 | Director | 4,328 | $55.05 | Sell | $238,256.40 | |
April 21, 2023 | CAO | 4,692 | $55.06 | Sell | $258,341.52 | |
April 18, 2023 | CEO | 1,211 | $52.04 | Sell | $63,020.44 | |
April 18, 2023 | Insider | 732 | $52.04 | Sell | $38,093.28 | |
April 17, 2023 | VP | 61,923 | $51.42 | Sell | $3,184,080.66 | |
April 17, 2023 | Director | 11,429 | $51.03 | Sell | $583,221.87 | |
March 31, 2023 | Director | 2,571 | $50.05 | Sell | $128,678.55 | |
March 29, 2023 | CAO | 4,688 | $47.79 | Sell | $224,039.52 |
Insiders are both buying and selling PTC Therapeutics Inc stock.
The insider traders at PTC Therapeutics Inc are: Stuart Walter Peltz, Mark Elliott Boulding, Christine Marie Utter, Neil Gregory Almstead, Emily Luisa Hill, Eric Pauwels, Mark Rothera, Allan Steven Jacobson, Matthew B Klein, Claudia De Oliveira Ri Hirawat, Marcio Souza, David P Southwell, Lee Scott Golden, Stephanie Okey, Dawn Svoronos, Pierre Gravier, Jerome B Zeldis, Michael Schmertzler, Hbm Healthcare Investments (Ca, Shane William Charles Kovacs, Michael Kranda, David Southwell, Adam Koppel, Alethia Young, Matthew B. Klein, Emma Reeve, Michael L Kranda, Richard Aldrich, Robert J Spiegel, and Robert Spiegel
The most active insider trader at PTC Therapeutics Inc is Stuart Walter Peltz with 31 trades.
Stuart Walter Peltz has sold the most PTC Therapeutics Inc stock with a total value of $85,044,720.20.
Adam Koppel has bought the most PTC Therapeutics Inc stock with a total value of $37,500,000.00.
The most recent insider trade for PTC Therapeutics Inc was on May 16, 2025.
The single biggest insider buy for PTC Therapeutics Inc was from Adam Koppel with a total value of $18,750,000.00 on June 25, 2013.
The single biggest insider sell for PTC Therapeutics Inc was from Stuart Walter Peltz with a total value of $21,253,437.00 on Dec. 7, 2020.